表紙
市場調査レポート

マイクロ流体技術:生物薬剤・医療アプリケーション

Microfluidic Technologies: BioPharmaceutical and Healthcare Applications 2013-2023

発行 Visiongain Ltd 商品コード 274546
出版日 ページ情報 英文 151 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=136.02円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
マイクロ流体技術:生物薬剤・医療アプリケーション Microfluidic Technologies: BioPharmaceutical and Healthcare Applications 2013-2023
出版日: 2013年06月25日 ページ情報: 英文 151 Pages
概要

世界のマイクロ流体技術市場は、2017年に35億米ドルの規模に達し、その後も2023年まで成長が続くと予測されています。

当レポートでは、世界のマイクロ流体技術市場について調査分析し、市場概要、セグメントおよび主要国別の市場分析と予測、SWOT分析、専門家へのインタビュー、主要企業のプロファイルなどをまとめ、概略下記の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 イントロダクション:マイクロ流体技術

  • マイクロ流体とは?
  • マイクロ流体技術のメリット
  • マイクロ流体デバイスの製造
  • マイクロ流体技術市場
  • マイクロ流体のアプリケーションはどこか?
  • マイクロ流体デバイスの規制

第3章 世界のマイクロ流体技術市場

  • マイクロ流体技術市場:概要
  • マイクロ流体技術市場:セグメント別
  • マイクロ流体技術市場予測
  • マイクロ流体技術市場動向

第4章 世界の体外診断市場におけるマイクロ流体技術

  • マイクロ流体ベースのIVD市場:概要
  • マイクロ流体ベースのIVD市場:セグメント別
  • マイクロ流体ベースのIVD市場予測
  • マイクロ流体ベースの臨床診断市場
  • マイクロ流体ベースのPOC診断市場
  • マイクロ流体ベースの分析デバイス市場
  • 結論

第5章 医薬品・ライフサイエンス研究市場におけるマイクロ流体技術

  • マイクロ流体ベースの医薬品・ライフサイエンス研究市場:概要
  • マイクロ流体ベースの医薬品・ライフサイエンス研究市場:セグメント別
  • マイクロ流体ベースの医薬品・ライフサイエンス研究市場予測
  • マイクロ流体ベースのゲノミクス市場
  • マイクロ流体ベースのプロテオミクス市場
  • 主なマイクロ流体ベースの医薬品・ライフサイエンスデバイス市場
  • 結論

第6章 ドラッグデリバリー市場におけるマイクロ流体技術

  • マイクロ流体ベースのドラッグデリバリー市場:概要
  • マイクロ流体ベースのドラッグデリバリー市場予測
  • 主なマイクロ流体ベースのドラッグデリバリーデバイス
  • 開発中のマイクロ流体ベースのドラッグデリバリーデバイス
  • 結論

第7章 主要国のマイクロ流体技術市場

  • マイクロ流体技術市場の地域別分析
  • マイクロ流体技術市場:地域別予測
  • 米国:リーダー市場
  • 欧州:EU5ヶ国の分析
  • 日本:2番目に大きな市場
  • 中国:強い成長の可能性
  • インド:急成長市場

第8章 マイクロ流体技術市場の主要企業

  • Agilent Technologies
  • PerkinElmer
  • Cepheid
  • Fluidigm Corporation
  • その他

第9章 マイクロ流体技術市場のSWOT分析

  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 調査インタビュー

第11章 結論

  • マイクロ流体技術市場
  • IVD市場
  • 医薬品・ライフサイエンス研究市場
  • ドラッグデリバリー市場
  • 総論

図表

目次

Microfluidics - how to find trends, opportunities and revenue prospects

Do you want to assess the potential of microfluidic technologies? Visiongain's new report gives you revenue predictions there from 2013, helping you stay ahead. You find financial data, trends, opportunities, and outlooks.

In that work you see forecasted sales to 2023 at overall world market, submarket (application), and national level. You assess those trends and technologies for life sciences, pharmaceuticals, medical devices, and in vitro diagnostics.

Analysis of what shapes the microfluidics industry and determines its potential

Discover, then, what the future holds for microfluidics and its applications. Read on to explore that industry and see what its future market could be worth.

Forecasts to 2023 and other analyses show you commercial opportunities

Besides revenue forecasting to 2023, you see financial results, growth rates, and market shares. You assess quantitative and qualitative analysis, business news, outlooks, and developments (R&D). You also gain 48 tables, 46 charts, and two interviews.

Our work lets you investigate the most promising and lucrative parts of microfluidics, helping you stay ahead in knowledge. Finding data you need there just got easier.

Now see how you can benefit your research, analyses, and decisions, also saving time.

Prospects for the world market and submarkets

Our new report shows revenue to 2023 for the overall world market. It also shows you individual forecasts of 11 microfluidic submarkets. Find revenues to 2023 for these applications:

  • In vitro diagnostics - with sub-forecasts for clinical diagnostics, point of care (POC) diagnostics, analytical devices, and other products
  • Pharmaceutical and life science research - with sub-forecasts for genomics, proteomics, cell-based assays, and other products
  • Drug delivery.

How will the microfluidics market expand? Which parts will most prosper? There you assess potential for sales.

Our study also discusses what stimulates and restrains that market. That analysis helps you identify potential and find ways for your business to benefit.

You find geographical revenue predictions too.

Forecasts of national markets for microfluidic technologies

In developed and developing countries, many sales opportunities for developers and producers of those technologies will occur from 2013. See where and how.

Our analyses show you individual revenue forecasts to 2023 for nine national markets and a regional block:

  • US
  • Japan
  • Germany, France, UK, Italy, and Spain (EU5)
  • EU (grouped regional forecast)
  • India and China.

There you find potential for the technology. Pharma and diagnostics companies face many opportunities worldwide. Our study explains, discussing crucial issues.

Developments and opportunities affecting microfluidics

Our report discusses issues and events affecting that industry and market from 2013:

  • Products in development - R&D and expanding applications
  • Microfluidic technologies and products available
  • Lab-on-a-chip technology, with wide range of biological uses
  • Production of devices - manufacturing issues
  • Regulation of microfluidic devices - the US and Europe.

That study also discusses other aspects of the field, including these:

  • Academia and industry - gaps and connections
  • Demand for advanced drug delivery methods
  • Microfluidics benefitting the biologics industry
  • Drug development - including genomics, proteomics, and cell-based assays
  • Delivery of drugs and vaccines - including microneedles, micropumps, and inhalers
  • Personalised medicine and stem cells.

There, you explore that industry's strengths, weaknesses, opportunities, and threats. You see what stimulates and restrains technology and business.

See, then, what the future holds.

Prominent companies in that biomedical field and its 2017 market value

What happens next? Our study predicts the world market for microfluidics will reach $3.5bn in 2017 - with strong growth - and expand further to 2023. See how high revenues can go.

That work shows you what technologies, products, and organisations hold greatest potential. Our analysis investigates these companies and many others:

  • Agilent Technologies
  • PerkinElmer
  • Cepheid
  • Fluidigm Corporation.

In our study you find 192 organisations covered. Also, you read two interviews with authorities in that industry. See what shapes it, discovering what participants do and say.

Microfluidic technologies hold great potential for investment, development, and revenue growth from 2013. You see how they can progress, benefiting companies.

Eight ways Microfluidic Technologies: Biopharmaceutical and Healthcare Applications 2013-2023 helps you

To sum up, our analysis gives you the following knowledge:

  • Revenue to 2023 for the world microfluidics market - discover that industry's overall sales potential
  • Revenues to 2023 for 11 world-level submarkets - investigate the potential of its applications, finding the most promising places for investments and revenues
  • Forecasts to 2023 for 9 national markets in North America, Europe, and Asia - find the best countries for revenues and potential growth
  • Discussions and data for companies - hear about developers and manufacturers' activities, capabilities, results, and outlooks
  • Review of R&D and prospects for market expansion - investigate developments, exploring possibilities for technological and commercial advances
  • Interviews with experts on microfluidics - discover what authorities in that field think, say, and do, helping you stay ahead
  • Analysis of what stimulates and restrains that industry and market - assess challenges and strengths, helping you compete and gain advantages
  • Prospects for established players and companies entering that sector - explore needs, practices and outlooks for future success.

Information found nowhere else

That work gives independent analysis. You receive business intelligence found only in our report, seeing where prospects are most rewarding.

With our study you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.

Assess progress and potential in microfluidics now, seeing what you can gain.

Table of Contents

1. Executive Summary

  • 1.1 Overview of Microfluidics Technology Market
  • 1.2 Aim, Scope and Format of this Report
  • 1.3 Chapters in the Report
  • 1.4 Research and Analysis Methods
  • 1.5 Glossary of Terms Relating to the Microfluidics Technology Market

2. Introduction to Microfluidics Technology

  • 2.1 What is Microfluidics?
    • 2.1.1 History of Microfluidics Technology
    • 2.1.2 Continuous Flow Microfluidics
    • 2.1.3 Digital Microfluidics
  • 2.2 Benefits of Microfluidics Technology
  • 2.3 Fabrication of Microfluidic Devices
  • 2.4 Where Does Microfluidics Technology Find Applications?
  • 2.5 The Microfluidic Technologies Market
    • 2.5.1 Microfluidics Technology in the In Vitro Diagnostics Market
    • 2.5.1.1 Clinical Diagnostics
    • 2.5.1.2 Point of Care (POC) Diagnostics
    • 2.5.1.3 Analytical Devices
    • 2.5.2 Microfluidics Technology in Pharmaceutical and Life Science Research
    • 2.5.2.1 Genomics
    • 2.5.2.2 Proteomics
    • 2.5.2.3 Cellular Assays
    • 2.5.3 Microfluidics Technology in Drug Delivery
    • 2.5.3.1 Increasing Popularity of Transdermal Drug Delivery
    • 2.5.3.2 Microneedles
    • 2.5.3.3 Micropumps
    • 2.5.3.4 Inhalers
  • 2.6 Regulation of Microfluidic Devices
    • 2.6.1 The US Regulation System
    • 2.6.2 Regulation of Laboratory Developed Tests
    • 2.6.3 The European Regulatory System
    • 2.6.3.1 Post Marketing Surveillance in the EU

3. The Global Microfluidic Technologies Market, 2013-2023

  • 3.1 Microfluidic Technologies Market: Overview
  • 3.2 Microfluidic Technologies Market by Segment, 2012
  • 3.3 Microfluidic Technologies Market Forecast, 2013-2023
  • 3.4 Microfluidic Technologies Market Trends, 2013-2023
    • 3.4.1 Increase in Chronic Disease Patient Population
    • 3.4.2 Shift towards Decentralisation
    • 3.4.3 Increased Awareness through Globalisation
    • 3.4.4 Growing Demand for Advanced Drug Delivery Methods
    • 3.4.5 Microfluidics Technology Benefitting Biologics Market
    • 3.4.6 Move towards Personalised Medicine
    • 3.4.7 Fast Changing Market

4. Microfluidics Technology in the World In Vitro Diagnostics Market, 2013-2023

  • 4.1 Microfluidics Based IVD Market: Overview
  • 4.2 Microfluidics Based IVD Market by Segment, 2012
  • 4.3 Microfluidics Based IVD Market Forecast, 2012-2017
  • 4.4 Microfluidics Based IVD Market Forecast, 2017-2023
  • 4.5 Microfluidics Based Clinical Diagnostics Market, 2012
    • 4.5.1 Microfluidics Based Clinical Diagnostics Market Forecast, 2012-2023
  • 4.6 Microfluidics Based POC Diagnostics Market, 2012
    • 4.6.1 Microfluidics Based POC Diagnostics Market Forecast, 2012-2023
    • 4.6.2 Leading Microfluidics Based POC Devices in the Market, 2013
    • 4.6.3 Microfluidics Based POC Devices in Development, 2013
  • 4.7 Microfluidics Based Analytical Devices Market, 2012
    • 4.7.1 Microfluidics Based Analytical Devices Market Forecast, 2012-2023
    • 4.7.2 Leading Microfluidics Based Analytical Devices in Market, 2013
  • 4.8 Conclusions

5. Microfluidics Technology in Pharmaceutical and Life Science Research Market, 2013-2023

  • 5.1 Microfluidics Based Pharmaceutical and Life Science Research Market: Overview
  • 5.2 Microfluidics Based Pharmaceutical and Life Science Research Market by Segment, 2012
  • 5.3 Microfluidics Based Pharmaceutical and Life Science Research Market Forecast, 2012-2017
  • 5.4 Microfluidics Based Pharmaceutical and Life Science Research Market Forecast, 2017-2023
  • 5.5 Microfluidics Based Genomics Market, 2012
    • 5.5.1 Microfluidics Based Genomics Market Forecast, 2012-2023
  • 5.6 Microfluidics Based Proteomics Market, 2012
    • 5.6.1 Microfluidics Based Proteomics Market Forecast, 2012-2023
  • 5.7 Microfluidics Based Cell-Based Assays Market, 2012
    • 5.7.1 Microfluidics Based Cell-Based Assays Market Forecast, 2012-2023
  • 5.8 Leading Microfluidics Based Pharmaceutical and Life Science Research Devices in Market, 2013
    • 5.8.1 LabChip: A Highly Advanced Research Platform
    • 5.8.2 2100 Bioanalyzer: Preferred Standard in a Research Lab
    • 5.8.3 Microcapillary Protein Crystallisation System Plug Maker (Emerald Biosystems)
    • 5.8.4 BioMark (Fluidigm Corporation)
    • 5.8.5 C1 Single-Cell Auto Prep System (Fluidigm Corporation)
    • 5.8.6 QX100ddPCR: A Leading Device in Digital PCR Technology
    • 5.8.7 RainDrop System (RainDance Technologies)
    • 5.8.8 Mondrian SP (NuGEN)
    • 5.8.9 IonPGM Sequencer (Life Technologies)
    • 5.8.10 Genome Analyzer (Illumina)
  • 5.9 Conclusions

6. Microfluidics Technology in the Drug Delivery Market, 2013-2023

  • 6.1 Microfluidics Based Drug Delivery Market: Overview
  • 6.2 Market Projection for Microfluidics Based Drug Delivery Market, 2012-2023
  • 6.3 Leading Microfluidics Based Drug Delivery Devices in Market, 2013
    • 6.3.1 MiniMed Paradigm Revel System: A Leading Insulin Pump
    • 6.3.2 MicronJet (Nanopass Technologies)
    • 6.3.3 Nanoject: A Device for Intradermal Vaccine Delivery
    • 6.3.4 Microstructured Transdermal System (MTS) Device
    • 6.3.5 Respimat: A New Generation Inhaler
    • 6.3.6 Spray Nozzles for Aerosol Inhaler Devices
  • 6.4 Microfluidics Based Drug Delivery Devices in Development, 2013
    • 6.4.1 Nanopump: A Miniaturised Drug Delivery Pump
    • 6.4.2 JewelPUMP: Hoping to Revolutionise the Life of Diabetic Patients
    • 6.4.3 SOLO Micropump: Smallest and Lightest Insulin Pump
    • 6.4.4 AdminPen: New Liquid Injection System
    • 6.4.5 PKA SoftTouch Microneedle: Breakthrough from PKA SoftTouch Corp?
    • 6.4.6 DrugMAT: Microneedle Patch for Drug/Vaccine Delivery
    • 6.4.7 MicroCor: Minimally Invasive Drug/Vaccine Delivery System
    • 6.4.8 Implantable Drug Delivery Device
  • 6.5 Conclusions

7. Leading National Microfluidic Technologies Markets, 2013-2023

  • 7.1 Regional Breakdown of the Microfluidic Technologies Market, 2012
  • 7.2 Microfluidic Technologies Market: Regional Forecast 2012-2023
  • 7.3 The US 2012-2023: Leading National Market
  • 7.4 Europe 2012-2023: Analysis of EU5
    • 7.4.1 Germany 2012-2023: Largest European Market
    • 7.4.2 France 2012-2023: Patient Demographics will Push Market Growth
    • 7.4.3 Italy 2012-2023: Slow Growth Owing to Economic Crisis
    • 7.4.4 Spain 2012-2023: Facing Cost Containment Measures
    • 7.4.5 UK 2012-2023: Budgetary Constraints
  • 7.5 Japan 2012-2023: Second Largest National Market in 2012
  • 7.6 China 2012-2023: Potential for Strong Growth
  • 7.7 India 2012-2023: Fastest Growing National Market

8. Leading Companies in the Microfluidic Technologies Industry, 2013

  • 8.1 Agilent Technologies
    • 8.1.1 Sales and Performance Analysis, 2012
    • 8.1.2 Diagnostics and Genomics Business Analysis, 2012
    • 8.1.3 Sales and Performance Analysis by Region, 2012
  • 8.2 PerkinElmer
    • 8.2.1 Sales and Performance Analysis, 2012
    • 8.2.2 Human Health Segment Analysis, 2012
  • 8.3 Cepheid
    • 8.3.1 Sales and Performance Analysis, 2012
    • 8.3.2 Product Sales by Category, 2012
    • 8.3.3 Product Sales by Region, 2012
  • 8.4 Fluidigm Corporation
    • 8.4.1 Sales and Performance Analysis, 2012
    • 8.4.2 Product Sales Analysis by Segment, 2012
    • 8.4.3 Product Sales by Region, 2012
  • 8.5 Other Companies, 2013

9. SWOT Analysis of the Microfluidic Technologies Market, 2013-2023

  • 9.1 Strengths
    • 9.1.1 Increase in Prevalence of Diseases Worldwide
    • 9.1.2 Ability to Fit an Entire Lab on to a Chip
    • 9.1.3 Wide Range of Biological Applications
  • 9.2 Weaknesses
    • 9.2.1 Microfluidics Remains an Emerging Field
    • 9.2.2 The Gap between Academia and Industry
    • 9.2.3 Limited Adoption of Microfluidics Technology
  • 9.3 Opportunities
    • 9.3.1 Growth of Personalised Medicine
    • 9.3.2 Microfluidic Devices for Stem Cell Research
    • 9.3.3 Point of Care Diagnostics Poised for Strong Growth
    • 9.3.4 Expansion into Developing National Markets
  • 9.4 Threats
    • 9.4.1 Complexity of Microfluidic Devices Posing Regulatory Challenges
    • 9.4.2 Lack of Sufficient Healthcare Coverage
    • 9.4.3 Medical Device Excise Tax

10. Research Interviews

  • 10.1 Interview with CYTOO Cell Architects
    • 10.1.1 The Current State of the Microfluidics Technology Market
    • 10.1.2 Role of Microfluidics in Cell-Based Assays
    • 10.1.3 Major Challenges Faced by Microfluidics Technology
    • 10.1.4 The Outlook for Microfluidics Technology
  • 10.2 Interview with GeneFluidics
    • 10.2.1 About GeneFluidics
    • 10.2.2 Microfluidics Technology Market Environment
    • 10.2.3 Impact of Microfluidics Technology on Personalised Medicine
    • 10.2.4 Obstacles to Market Growth

11. Conclusions of the Study

  • 11.1 The Microfluidic Technologies Market, 2013-2023
  • 11.2 The IVD Market
  • 11.3 The Pharmaceutical and Life Science Research Market
  • 11.4 The Drug Delivery Market
  • 11.5 Concluding Remarks

List of Tables

  • Table 3.1 Microfluidic Technologies Market: Sales ($m) and Market Shares (%) by Segment, 2012
  • Table 3.2 Microfluidic Technologies Market Forecast ($m, %) by Segment, 2012-2017
  • Table 3.3 Microfluidic Technologies Market Forecast ($m, %) by Segment, 2017-2023
  • Table 3.4 Key Mergers and Acquisitions in the Microfluidic Technologies Market, 2011
  • Table 4.1 Microfluidics Based IVD Market: Sales ($m) and Market Shares (%), 2012
  • Table 4.2 Microfluidics Based IVD Market Forecast ($m, %), 2012-2017
  • Table 4.3 Microfluidics Based IVD Market Forecast ($m, %), 2017-2023
  • Table 4.4 Microfluidics Based Clinical Diagnostics: Market Forecast ($m, %), 2012-2017
  • Table 4.5 Microfluidics Based Clinical Diagnostics: Market Forecast ($m, %), 2017-2023
  • Table 4.6 Microfluidics Based POC Diagnostics: Market Forecast ($m, %), 2012-2017
  • Table 4.7 Microfluidics Based POC Diagnostics: Market Forecast ($m, %), 2017-2023
  • Table 4.8 Leading Microfluidics Based POC Devices in the Market, 2013
  • Table 4.9 Microfluidics Based POC Devices in Development, 2013
  • Table 4.10 Microfluidics Based Analytical Devices: Market Forecast ($m, %), 2012-2017
  • Table 4.11 Microfluidics Based Analytical Devices: Market Forecast ($m, %), 2017-2023
  • Table 4.12 Leading Microfluidics Based Analytical Devices in the Market, 2013
  • Table 5.1 Microfluidics Based Pharmaceutical and Life Science Research Market: Sales ($m) and Market Shares (%) by Segment, 2012
  • Table 5.2 Microfluidics Based Pharmaceutical and Life Science Research Market Forecast ($m, %) by Segment, 2012-2017
  • Table 5.3 Microfluidics Based Pharmaceutical and Life Science Research Market Forecast ($m, %) by Segment, 2017-2023
  • Table 5.4 Microfluidics Based Genomics Market Forecast ($m, %), 2012-2017
  • Table 5.5 Microfluidics Based Genomics Market Forecast ($m, %), 2017-2023
  • Table 5.6 Microfluidics Based Proteomics Market Forecast ($m, %), 2012-2017
  • Table 5.7 Microfluidics Based Proteomics Market Forecast ($m, %), 2017-2023
  • Table 5.8 Microfluidics Based Cell-Based Assay Market Forecast ($m, %), 2012-2017
  • Table 5.9 Microfluidics Based Cell-Based Assay Market Forecast ($m, %), 2017-2023
  • Table 5.10 Leading Microfluidics Based Pharmaceutical and Life Science Research Devices in Market, 2013
  • Table 6.1 Microfluidics Based Drug Delivery: Market Forecast ($m, %), 2012-2017
  • Table 6.2 Microfluidics Based Drug Delivery: Market Forecast ($m, %), 2017-2023
  • Table 6.3 Leading Microfluidics Based Drug Delivery Devices in the Market, 2013
  • Table 6.4 Microfluidics Based Drug Delivery Devices in Development, 2013
  • Table 7.1 Leading National Microfluidic Technologies Market: Sales ($m) and Market Shares (%), 2012
  • Table 7.2 Microfluidic Technologies: Market Forecasts ($m, %) by Leading Country, 2012-2017
  • Table 7.3 Microfluidic Technologies: Market Forecasts ($m, %) by Leading Country, 2017-2023
  • Table 7.4 European Microfluidic Technology Markets: Sales ($m) and Market Shares (%) in Leading National Markets, 2012
  • Table 7.5 European Microfluidic Technology Markets: Forecasts ($m, %) by Leading Country, 2012-2017
  • Table 7.6 European Microfluidic Technology Markets: Forecasts ($m, %) by Leading Country, 2017-2023
  • Table 8.1 Agilent Technologies: Net Revenue ($bn) and Revenue Shares (%) by Business Group, 2012
  • Table 8.2 Agilent Technologies: Net Revenue ($bn) and Revenue Shares (%) by Region, 2012
  • Table 8.3 PerkinElmer: Revenue ($bn) and Revenue Shares (%) by Segment, 2012
  • Table 8.4 Cepheid: Revenue ($m) and Revenue Shares (%) by Segment, 2012
  • Table 8.5 Cepheid: Revenue ($m) and Revenue Shares (%) by Product Category, 2012
  • Table 8.6 Cepheid: Revenue ($m) and Revenue Shares (%) by Region, 2012
  • Table 8.7 Fluidigm Corporation: Revenue ($m) and Revenue Shares (%) by Segment, 2012
  • Table 8.8 Fluidigm Corporation: Revenue ($m) and Revenue Shares (%) by Product Segment, 2012
  • Table 8.9 Fluidigm Corporation: Revenue ($m) and Revenue Shares (%) of Products by Region, 2012
  • Table 8.10 Other Companies in the Microfluidic Technologies Market, 2013
  • Table 9.1 SWOT Analysis of the Microfluidic Technologies Market, 2013
  • Table 11.1 Segments in the Microfluidic Technologies Market: Sales ($m) in 2012, 2017, 2019 and 2023

List of Figures

  • Figure 3.1 Microfluidic Technologies Market: Sales ($m) by Segment, 2012
  • Figure 3.2 Microfluidic Technologies Market: Market Shares (%) by Segment, 2012
  • Figure 3.3 Microfluidic Technologies Market Forecast ($m), 2012-2023
  • Figure 3.4 Microfluidic Technologies Market Forecasts ($m) by Segment, 2012-2023
  • Figure 4.1 Microfluidics Based IVD Market: Sales ($m) by Segment, 2012
  • Figure 4.2 Microfluidics Based IVD Market: Market Shares (%) by Segment, 2012
  • Figure 4.3 Microfluidics Based IVD Market Forecast ($m), 2012-2023
  • Figure 4.4 Microfluidics Based Clinical Diagnostics Market Forecast ($m), 2012-2023
  • Figure 4.5 Microfluidics Based POC Diagnostics Market Forecast ($m), 2012-2023
  • Figure 4.6 Microfluidics Based Analytical Devices Market Forecast, 2012-2023
  • Figure 5.1 Microfluidics Based Pharmaceutical and Life Science Research Market: Sales ($m) by Segment, 2012
  • Figure 5.2 Microfluidics Based Pharmaceutical and Life Science Research Market: Market Shares (%) by Segment, 2012
  • Figure 5.3 Microfluidics Based Pharmaceutical and Life Science Research Market Forecast ($m), 2012-2023
  • Figure 5.4 Microfluidics Based Genomics Market Forecast ($m), 2012-2023
  • Figure 5.5 Microfluidics Based Proteomics Market Forecast ($m), 2012-2023
  • Figure 5.6 Microfluidics Based Cell-Based Assay Market Forecast ($m), 2012-2023
  • Figure 6.1 Microfluidics Based Drug Delivery Market Forecast ($m), 2012-2023
  • Figure 7.1 Microfluidic Technology Market: Sales ($m) in Leading National Markets, 2012
  • Figure 7.2 Microfluidic Technology Market: Market Shares (%) in Leading National Markets, 2012
  • Figure 7.3 The US Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 7.4 The European Microfluidic Technology Markets: Sales ($m) in Leading National Markets, 2012
  • Figure 7.5 The European Microfluidic Technology Markets: Market Shares (%) in Leading National Markets, 2012
  • Figure 7.6 The European Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 7.7 The German Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 7.8 The French Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 7.9 The Italian Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 7.10 The Spanish Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 7.11 The UK Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 7.12 The Japanese Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 7.13 The Chinese Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 7.14 The Indian Microfluidic Technology Market Forecast ($m), 2012-2023
  • Figure 8.1 Agilent Technologies: Net Revenue ($bn) by Business Group, 2012
  • Figure 8.2 Agilent Technologies: Revenue Shares (%) by Business Group, 2012
  • Figure 8.3 Agilent Technologies: Revenue Shares (%) by Region, 2012
  • Figure 8.4 PerkinElmer: Revenue Shares (%) by Segment, 2012
  • Figure 8.5 Cepheid: Revenue ($m) by Segment, 2012
  • Figure 8.6 Cepheid: Revenue Shares (%) by Segment, 2012
  • Figure 8.7 Cepheid: Revenue ($m) by Product Category, 2012
  • Figure 8.8 Cepheid: Revenue Shares (%) by Product Category, 2012
  • Figure 8.9 Cepheid: Revenue Shares (%) by Region, 2012
  • Figure 8.10 Fluidigm Corporation: Revenue Shares (%) by Segment, 2012
  • Figure 8.11 Fluidigm Corporation: Revenue ($m) by Product Segment, 2012
  • Figure 8.12 Fluidigm Corporation: Revenue Shares (%) by Product Segment, 2012
  • Figure 8.13 Fluidigm Corporation: Revenue Shares (%) of Products by Region, 2012
  • Figure 11.1 Microfluidic Technologies Market: Sales ($m) in 2012, 2017, 2019 and 2023
  • Figure 11.2 Segments in the Microfluidic Technologies Market: Sales ($m) in 2012, 2017, 2019 and 2023

Companies Listed

  • 3M
  • Abaxis
  • Abbott
  • Achira Labs
  • Advalytix
  • Advanced Liquid Logic
  • Advion
  • AES Laboratoire
  • Affymetrix
  • Agilent Technologies
  • Akkonni Biosystems
  • Alere
  • American Heart Association and American College of Cardiology (AHA/ACC)
  • Applied Biophysics
  • Arcxis Biotechnologies
  • Artemis Health
  • Atonomics
  • Axis-Shield
  • BaiO
  • Beckman Coulter
  • Becton Dickinson
  • BellBrook Laboratories
  • Biocius
  • Biodetection Instruments
  • Biodot
  • Biofluidix
  • BioForce Nanosciences
  • Biolithic
  • Bionas
  • Bio-Rad Laboratories
  • Bioscale
  • Biosite
  • Biosurfit
  • BioTray
  • Biotrove
  • BioVitesse
  • Boehringer Ingelheim
  • Boston Microfluidics
  • California Institute of Regenerative Medicine (CIRM)
  • Caliper Life Sciences
  • Cambridge Biomagnetics
  • Capilix
  • CapitalBio Corporation
  • CEA Laboratory of Electronics and Information Technologies (LETI)
  • Cellanyx
  • Cellasic
  • Cellectricon
  • Cellix
  • Celula
  • Center for Devices and Radiological Health (CDRH)
  • Cepheid
  • Cetoni
  • Claros Diagnostics
  • ClonDiag
  • Corium International
  • Crospon
  • Cyclofluidic
  • Cynvenio
  • CYTOO Cell Architects
  • Dako
  • Daktari Diagnostics
  • Dalian Institute of Chemical Physics (DICP)
  • Danaher
  • Debiotech
  • Diagnostics For All
  • Digilab Global
  • DNA Electronics
  • Dolomite Microfluidics
  • Eksigent Technologies
  • Emerald Biosystems
  • Epigem
  • Epocal
  • Fluidigm Corporation
  • Fluidmedix
  • Fluidware Technologies
  • Fluxion Biosciences
  • FocusDx
  • Food and Drug Administration (FDA)
  • GE Healthcare
  • GeneFluidics
  • GeneWave
  • Geniachip
  • GnuBio
  • Gyros
  • Habsel
  • Hain Lifesciences
  • Handylab
  • Helicos Biosciences
  • Hewlett Packard
  • IBM
  • Idaho Technologies
  • Illumina
  • IMEC
  • Incept BioSystems
  • Indian Institute of Technology (IIT)
  • Infineon AG
  • Innogenetics NV
  • Inostics
  • Institute of MicroAnalytical Technology (IMAS)
  • IonTorrent
  • IQuum
  • Janssen Pharmaceuticals
  • Lab901
  • Labcyte
  • labNow
  • Labsmith
  • LC Sciences
  • LeukoDx
  • Life Technologies
  • Massachusetts Institute of Technology
  • Mbio Diagnostics
  • Medimate
  • Medingo
  • Medspray
  • Medtronic
  • Micro/Nano Fluidics Focus (MF3) Centre
  • Micro2Gen
  • MicroCHIPS
  • Micronics
  • Micronit
  • MicroTEC
  • Micrux Technologies
  • Millipore
  • Mode Diagnostics
  • Molecular Vision
  • Mycrolab
  • Nanion Technologies
  • nanoBiosciences
  • Nanobiosym
  • NanoEnTek
  • Nanogen
  • Nanomix
  • Nanopass Technologies
  • Nanopoint Imaging
  • Nanosphere
  • NanoTerra
  • National Health Service (NHS)
  • National Institutes of Health (NIH)
  • Nemaura Pharma
  • Novartis
  • NuGEN
  • On-Q-ity
  • Opko Diagnostics
  • Osmotex
  • Panasonic
  • Pathogenetix
  • PerkinElmer
  • Philips
  • PKA SoftTouch Corp
  • PositiveID Corporation
  • Procter & Gamble
  • Proteus Biomedical
  • Qiagen
  • QuantaLife
  • QuantumMDX
  • Quest
  • Quorum Technologies
  • RainDance Technologies
  • Rheonix
  • Roche
  • Samsung
  • Scienion
  • Sensimed
  • SensiVida Medical Technologies
  • SFC Fluidics
  • Shanghai BioChip
  • Shanghai Institute of Microsystem and Information Technology (SIMIT)
  • Siemens
  • Silicon Biosystems
  • Siloam Biosciences
  • Singapore Economic Development Board (EDB)
  • SlipChip LLC
  • Sony
  • Spartan Bioscience
  • Sphere Medical
  • Stanford University
  • STMicroelectronics
  • SurModics
  • TearLab
  • TECAN
  • TheraJect Inc
  • Thermo Fisher Scientific
  • Triversa Nanomate
  • Tufts Center for the Study of Drug Development
  • UFluidix
  • United Gene
  • University of Tokyo
  • Veridex
  • Vivacta
  • Wasatch Microfluidics
  • Wave 80 Biosciences
  • World Health Organization (WHO)
  • Xona Microfluidics
  • Yulong
Back to Top